about
Colorectal cancer risk variants on 11q23 and 15q13 are associated with unexplained adenomatous polyposis.Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.A white raven detected by imaging.The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers.Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.Professionals' knowledge, attitude and referral behaviour of preimplantation genetic diagnosis for hereditary breast and ovarian cancer.Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility.Cancer Risks for PMS2-Associated Lynch SyndromeHeight and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization StudyOvarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriersGenetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) CThe Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort EffectOral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort StudyLarge scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classificationAn alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndromeMendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
P50
Q37467854-DF3B6213-923D-4152-AFF5-B152823CF57FQ37595954-E1B810AC-3EB8-4FBB-ACD2-CDD0673D52AFQ38772089-9828F1C9-C7C4-43BD-9718-437CF24D8547Q41156873-875923C8-0AB1-4E2D-86AD-C6B3947BC046Q41642720-7A37E889-8BF3-4AD7-975D-35031CB127CBQ41685035-97E55D0B-015C-4F15-A529-1B3C5D3912F6Q47192712-F5AD8BBC-F40D-4570-A925-0A6D79AAEA32Q48251790-595498E9-CA0C-44C3-B9E6-1CFC3FF7CE6FQ57284561-34BD9549-2799-4514-81A2-8AAE74FB3337Q57471595-0B7C5EFE-964A-4016-9ABA-B57DBBF95B9BQ89224654-3DA06E04-7501-4F5D-B87B-DDF46F7DA315Q90089832-E0D1799F-AF98-4848-80A1-5D47E5975680Q92060065-D497457E-149D-4130-989A-B41E916CA1D3Q92281866-9AFAFA2C-0043-49C1-A3E2-6C3168441749Q92313654-91C075E2-7911-4970-825A-C571FCF280BBQ92783253-61BCFDC1-D0F1-47F1-91DA-0E71718AFBD0Q92860654-D9A9E260-590D-4660-9A20-B8CA1F7D1AE2
P50
description
researcher
@en
wetenschapper
@nl
name
Encarna B Gómez García
@en
Encarna B Gómez García
@nl
type
label
Encarna B Gómez García
@en
Encarna B Gómez García
@nl
prefLabel
Encarna B Gómez García
@en
Encarna B Gómez García
@nl
P31
P496
0000-0003-4999-8847